Summary The purpose of these experiments was to test the hypothesis that impaired glucose-stimulated insulin secretion in NIDDM is due to mutations in the islet beta cell/liver glucose transporter (GLUT 2) gene. Using oligonucleotide primers flanking each of the 11 exons, the structural portion of the gene was studied by PCR-SSCP analysis. DNA from African-American females (n = 48), who had gestational diabetes but developed overt NIDDM after delivery, was studied. Each SSCP variant was sequenced directly from genomic DNA. Two amino acid substitutions from the previously reported sequence were found, one in exon 3 and the other in exon 4B. Four additional silent mutations in the coding region, and six intron mutations outside the splice junction consensus sequences, were also identified. The mutation GTC x ATC in exon 4B substituted Va1197 to Ile ~97. This amino acid substitution was found in only one NIDDM patient in a single allele, and was not found in 52 control subjects. This residue exists in the fifth membrane spanning domain, and Val at this position is conserved in mouse and rat GLUT 2, and human GLUT 1 to GLUT 4. The other codon change in exon3, ACT xATT, substituted Thr H~ to Ile la~ in the second membrane spanning domain. To determine the frequency of this non-conservative amino acid substitution, a PCR-LCR assay was developed. This assay was simple and highly specific for detection of this single nucleotide substitution. The allelic frequency of the ATT (Ile 1~~ in NIDDM patients (39.6%, n = 48) and that in controls (47.1%, n = 52) did not differ (p --0.32, Fisher's exact test). In conclusion, we identified two variant GLUT 2 glucose transporters in a subset of NIDDM patients. The rare variant in exon 4 B may contribute to the diabetic susceptibility and awaits further investigation. However, structural abnormalities of the GLUT 2 transporter associated with NIDDM appeared to be rare and were not likely to be a major determinant of genetic susceptibility to this type of diabetes in the population studied. [Diabetologia (1994) 37: 420-427] 
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14%
Values are shown as mean + SD or percent. ap < 0.001 grees of familial autosomal dominant early-onset NIDDM [11, 25] and late-onset NIDDM [13, 24, 26] failed to show evidence of the contribution of this locus to the genetic susceptibility to NIDDM, with the exception of one positive association study [27] . Population studies are limited in sensitivity to detect heterogeneity within the disease locus [28] . The multifactorial nature of NIDDM also hampers linkage analysis in families [29, 30] . Thus, the contribution of GLUT 2 mutations to the genetic susceptibility to NIDDM has not been determined.
To circumvent the limitations of population and linkage studies, we have employed direct single nucleotide level analysis of the gene by PCR-SSCP analysis [31] and studied 48 African-American females with NIDDM. We also developed a simple highly specific method for detection of single base changes using thermostable DNA ligase and PCR. This method was applied to determine the frequency of a common amino acid substitution in exon 3 of the GLUT 2 gene, detected by SSCP and sequencing.
genetic factors determining susceptibility to NIDDM are still largely unknown.
GLUT 2, the major glucose transporter isoform of pancreatic islet beta cells, is also expressed in hepatocytes and in epithelial cells of the kidney and small intestine [15, 16] . This glucose transporter is unique because of its low affinity for glucose (Km 15-20 mmol/1), in contrast to other high affinity glucose transporters which are saturated at 1-3 mmol/1 glucose [17] . GLUT 2 and glucokinase, a low affinity hexokinase with a Km for glucose within the physiological range of plasma glucose, are co-localized in islet beta cells. This observation led to the hypothesis that these two proteins operate in tandem to provide islet beta cells with a mechanism responding to subtle changes in plasma glucose concentrations [18, 19] . Although the first phosphorylation step of glucose catalysed by glucokinase is the rate limiting step [20] , glucose must be transported rapidly into the cell. High transport capacity of GLUT 2 maintains the rapid equilibrium of glucose concentration across the plasma membrane in the wide range of changes of plasma glucose [21] . Thus GLUT 2 plays a permissive role in the earliest stage of the glucose sensing mechanism. Furthermore, the possibility of physical interaction between GLUT 2 and glucokinase to form a junctional glucose sensing system has been suggested [18, 19] . Therefore, significant reduction of transporter function caused by inherited defects in the gene may lead to a characteristic of NIDDM, i. e. inappropriate insulin secretion relative to the plasma glucose concentration. Thus, the gene encoding this transporter has been considered as a prime candidate for the determinants of genetic susceptibility to NIDDM.
Previous analyses of the GLUT 2 locus by population studies [22] [23] [24] and by linkage analyses in the pedi-
Subjects and methods

Subjects
Study subjects were chosen from African-American females who were ascertained through diagnosis of gestational diabetes during pregnancy, and development of overt diabetes after delivery. We chose this subtype of NIDDM because beta-cell defects were likely to be involved in the development of the disease (see Discussion). This is a subsample from a previous study [32, 33] . The first 48 overt diabetic patients were included for the present study and were studied by PCR-SSCP analysis for each exon. The clinical characteristics are shown in Table 1 . Although the control groups were younger and leaner than study group, they were matched for the ethnic group, and they received similar prenatal care and gave birth within the same health care system [33] . The difference in the family history (89% vs 14 %) merely reflected the hereditary nature of NIDDM. Interestingly, only 32 % of study subjects had a family history of NIDDM in the first degree relatives. The study was conducted under the approval of the Human Studies Committee and informed consent was obtained from all participants.
PCR-SSCP analysis
Genomic DNA was extracted from peripheral blood nuclear cells [34] and exons of the GLUT 2 gene, including exon-intron boundaries, were amplified using flanking oligonucleotide primers shown in Table 1 (Primer sequences were generously provided by Dr. G. I. Bell, University of Chicago, Chicago, Ill., USA). Oligonucleotides were synthesized on an ABI DNA synthesizer Model 380B by the Protein Chemistry Laboratory at Washington University Medical Center. PCR reactions were performed in 10 gl volumes for 30 cycles as described [35] . Annealing temperatures and MgC12 concentrations used for each amplification reaction are shown in Table 2 were added on the ends of Thr-specific oligonucleotides ( # 435, # 436, shown by lower cases) so that ligation products for each allele could be distinguished by polyacrylamide gel electrophoresis ton, Mass., USA). All other exons were uniformly labelled with [ct-32p]dCTP (NEN) during PCR. Exon 3 and exons 9-10 PCR products were cut with PvulI or RsaI, respectively, prior to SSCP electrophoresis to increase the sensitivity of the analysis. Exon 4 A PCR product was cut with BsmA1 to remove the polymorphic CA repeat region that is located in the intron 9 bp downstream from exon 4 A [36] . Restriction digestion was performed under the following conditions: 10 gl PCR product, 1 x recommended restriction buffer, i mg/ml bovine serum albumin, 4-6 U restriction enzyme in a total volume of 15 gl. Digests were incubated at the appropriate temperature for 3 h. Six microlitres of stop solution containing 95 % formamide, 20 mmol/1 EDTA were added to the PCR reaction following thermal cycling. After heat-denatured by boiling for 5 min, 4 gl of the mixture was then analysed by two types of gels; 5 % Hydrolink (AT Biochem, Malvern, Pa., USA), i x TBE gel (0.089 mmol/1 Trizma base, 0.089 mmol/1 Boric acid, 0.002 retool/1 EDTA) electrophoresed at 4-6 W for 16 h, and 8% polyacrylamide (100:1 acrylamide:bis-acrylamide), 5% glycerol, I x TBE gel run at 11-14 W for 16 h. Both were run with i x TBE electrophoresis buffer. Gels were then dried and exposed to autoradiograph film with intensifying screen for 3 to 5 h at -80 ~ Sequencing of PCR products, in which variations were observed on SSCR was performed using the cycle sequencing kit (Bethesda Research Laboratories, Gaithersburg, Md., USA) as previously described [35] . The sequence was confirmed by sequencing in both directions. For GTC x ATC change in exon 4B substituting Va1197 to Ile, and the intron 5 common polymorphism, the presence of the base substitution was further confirmed by the restriction digestion of the PCR products. The exon 4B variant removes a Mae III restriction site, and the intron 5 polymorphism eliminates an MboI site. The restriction digestion was performed as described above and analysed on agarose gel electrophoresis. Those specific restriction analyses were utilized to determine the frequency of the variants.
PCR-allele specific LCR
To determine the frequency of exon 3 variant ACT 11~ x ATT, substituting Thr 1l~ to Ile, PCR-allele specific LCR was developed [37] . The following oligonucleotides were synthesized and used (Fig. 1, 5 ' to 3'): TGCATCATTCTTT GGTGGGTGGC ( # 439, common, sense-strand), TCATTCCACCAACTGCAA-AGCTGG ( # 438, common, antisense-strand), GTTCAGCTT-TGCAGTTGGTGGAATGAC ( # 435, Thr-specific, sensestrand), GTTCCACCCACCAAAGAATGATGCAG ( # 436, Thr-specific, antisense strand), CAGCTTTGCAGTTGGTG-GAATGAT (# 437, Ile-specific, sense-strand), CCACCCAC-CAAAGAATGATGCAA (#440, Ile-specific, antisensestrand). As a target DNA for LCR assay, exon 3 of GLUT 2 gene was PCR amplified from genomic DNA with the condition used for PCR-SSCP analysis. One microlitre of the 10 gl PCR product was used for LCR reaction. LCR was carried out in 10 gl containing i x ligation buffer (20 mmol/1 Tris-Hcl pH 7.6,25 mmol/1 potassium acetate, 10 mmol/1 magnesium acetate, 10 mmol/1 dithiothreitol, I mmol/1 NAD, 0.1% Triton X-100), 1.5 U Taq ligase (New England Biolabs, Beverly, Mass., USA), target DNA and 0.5 gmol/1 each of the six primers with common sense-strand oligonucleotide (# 439) 32p-end labelled. Samples were processed through 35 cycles of a two-step chain reaction: 95 ~ for 1 min and 62 ~ for I min following a 4-min initial denaturation at 95 ~ After the thermal cycling, 6 gl of stop solution (see above) was added and samples were analysed on a standard sequencing gel for 45 rain to 1 h. Gels were dried and subjected to autoradiography at-80 ~ for 3 to 5 h.
Statistical analysis
Biostatistical analysis was performed as previously described [32] . Briefly, differences between groups with quantitative variables were evaluated by unpaired (two-tailed) Student's t-tests and differences in proportions were evaluated by chi-square test. The association of variant alleles with NIDDM were analysed by 2 x 2 contingency tables. A chi-square test of independence was performed with Yates' correction applied on Fisher's exact test where appropriate. 
Results
The entire coding region of the G L U T 2 gene was examined for single base changes in 48 NIDDM patients, directly from genomic D N A by PCR-SSCP analysis. A total of 12 SSCP variants were observed. The sequence changes responsible for the conformational polymorphisms were determined by direct sequencing of the PCR products and compared with the reported human GLUT 2 sequence [38] . Allelic frequencies for each variant were determined and are summarized in Table 3 .
In the human GLUT 2 gene two amino acid substitutions were identified, one in exon 3, and the other in exon 4B.The codon change in exon 3, ACTll~215 ATT H~ substituted Thr 11~ to Ile 1~~ in the second membrane spanning domain. To evaluate whether this amino acid substitution was associated with the diabetic phenotype, the frequency was determined in both diabetic patients and control subjects by a PCR-LCR assay. For LCR assay, we designed the allele specific diagnostic oligonucleotides in a different length for each allele (Fig. 1) , and L C R was performed under the presence of two diagnostic oligonucleotides specific for both alleles to determine the genotype by a single reaction. After the LCR, the products were separated by electrophoresis and two alleles were distinguished by the size of the products. The specificity of the assay was tested on the individuals whose genotypes were confirmed by sequencing. As shown in Figure 2 , the specificity of the assay was high and there was virtually no background.
When typed, the Thr 11~ to Ile 11~ substitution was found to be common. In 48 NIDDM patients, Thr/Thr (homozygote) was observed in 18 individuals (37. The other missense mutation, (Va1197 to Ile roT) in exon 4B (SSCP pattern shown in Fig. 3 A) , was found in i of 96 alleles in N I D D M patients, and in 0 of 104 alleles in normal control subjects. The presence of this mutation was further confirmed by restriction digestion of the exon 4 B P C R products (Fig. 3 B) . The mutation removed a Mae III restriction site ( G T C A C~A T -CAC).
Four additional silent mutations were identified in the coding region, two of which were common, ACG(Thr19S)~ACA(Thr19S), allelic frequency of 30.2% and TTC(Phe479)---~ TTT(Phe479), allelic frequency of 55.2 %. The other two were rare and observed in only one individual in heterozygous states with c o m m o n alleles (Table 3) . Six intron mutations were also found outside the consensus sequences of splice junction ( Table 4 ). The intron 5 variant was c o m m o n and observed in 38.5% of alleles in diabetic patients. These appeared to be functionally silent.
As we observed previously [32] , glycerol gel is more sensitive to detect the base pair variation. The variations which result in the amino acid substitutions (Thr tl~ and Va1197) were detected on both gel conditions. All the variations were detected on the gel containing the glycerol, and all but one variant (substitution of C with T at -79 of intron) was detected on the non-glycerol gel.
Discussion
The entire coding sequence of the h u m a n G L U T 2 gene, encoded by 11 exons [39] , including exon-intron boundaries and adjacent introns, was examined at the single nucleotide level by PCR-SSCP analysis. The patients chosen for study were African-American females who were diagnosed with gestational diabetes at perinatal examination, and developed overt diabetes after delivery. Pregnancy is a physiological state of insulin resistance [40] . It has been suggested that because all pregnant women are insulin resistant, those who have beta-cell dysfunction are more likely to develop diabetes during the gestational period [41] . Thus, the Ile 197) in exon 4B was found in 1 allele of 48 diabetic patients (96 alleles), and was not observed in 52 normal control subjects (104 alleles). This residue exists in the fifth membrane spanning domain and Val at this position is conserved in mouse, rat GLUT 2 [42] and human GLUT 1 to GLUT 4 [42] . The functional significance of this mutation has yet to be determined by the kinetic study of the variant GLUT 2 expressed in Xenopus oocytes [43] . The Thr 11~ to Ile 11~ substitution in exon 3 was common. Neither the allelic nor genotypic frequencies differed between NIDDM patients and control subjects, showing no association between this amino acid substitution and the disease status, although sample size is rather small, and a minor contribution to the risk of disease susceptibility could not be excluded. This mutation was also observed in Pima Indians [44] . When compared with previously reported amino acid sequences of human glucose transporters, only GLUT 2 had Thr in this position, while other low Km transporters had Ile in the corresponding position [41] . Although in rat and mouse GLUT 2 [17] , non-polar hydrophobic amino acid Val was found in the corresponding position, it would be still an interesting speculation that this nonconservative amino acid substitution in the second membrane spanning domain may alter the function by perhaps changing the affinity to glucose. This hypo-425 thesis can also be tested directly by the expression experiment [42] .
No difference in either the allelic or genotypic frequency of these two amino acid substitutions was found between the diabetic and control groups, however the possibility of a minor contribution has not been excluded by the present study. The sample size examined was small relative to what may be needed to detect minor susceptible factors in polygenic diseases. A similar PCR-SSCP analysis of the angiotensinogen gene in a population of hypertensive patients required a study of 499 patients and 238 controls to demonstrate a highly significant role of variants of this gene in susceptibility to hypertension [45] .
Although SSCP is a sensitive assay to detect a single base change, it is not a specific assay for a given nucleotide change and occasionally different base changes show indistinguishable patterns [46] . Therefore, to determine the frequency of the common amino acid substitution in exon 3, we utilized the allele specific LCR assay. Several allele specific assays have been developed including restriction enzyme digestion, allele specific oligonucleotide hybridization and allele specific PCR [47] . However, restriction analysis is only possible if the base change creates or eliminates a certain restriction site. Allele specific oligonucleotide hybridization and allele specific PCR require precise assay conditioning to verify the specificity.
An LCR relies on the character of thermostable ligase that links two adjacent oligonucleotides when these nucleotides hybridize to a complementary target and accurately base-pair at the junction [36] . In order to determine the genotype by a single reaction, here we designed the allele specific diagnostic oligonucleotides in a different length for each allele, and LCR was performed under the presence of two diagnostic oligonucleotides specific for both alleles. Under this condition, amplification was less efficient because for each allele, the presence of the mismatched oligonucleotide and its annealing to the target interferes with the LCR amplification of the allele. This was overcome by using PCR amplified target DNA rather than genomic DNA. After the LCR, two alleles were distinguished by size on electrophoresis. This simple and highly specific method would be useful to determine the frequency of single base change polymorphisms identified by SSCR especially when those changes do not alter the restriction enzyme recognition sites.
In conclusion, we identified two variant GLUT 2 glucose transporters in a subset of patients with NIDDM. The rare variant in exon 4 B may contribute to the diabetic susceptibility and awaits further investigation. However, structural abnormalities of the GLUT 2 transporter associated with NIDDM appeared to be rare. Although the sensitivity of PCR-SSCP is not 100 To [34] and regulatory regions of this gene were not examined in the current study, our analysis, combined with previous population association studies and linkage analyses, suggests that mutations in the GLUT 2 gene are not major determinants of diabetic susceptibility.
